Allergen extract vs. component sensitization and airway inflammation, responsiveness and new-onset respiratory disease

Clinical and Experimental Allergy

Volumn 46, Issue 5, 2016, Pages 730-740

  Patelis, A ^a   Gunnbjornsdottir, M ^a   Alving, K ^a   Borres, M P ^a,b   Hogman M ^a   Janson, C ^a   Malinovschi, A ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Thermo Fisher Scientific   (United States)

Author keywords

Allergen components; Asthma; Extract based; FeNO; Rhinitis

Indexed keywords

ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; NITRIC OXIDE; PROFILIN; BIOLOGICAL MARKER; METHACHOLINE CHLORIDE;

ADULT; ALLERGY RAPID TEST; ARTICLE; ASTHMA; ASTHMATIC STATE; BIRCH; BODY MASS; BRONCHUS REACTIVITY; CAT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHLEUM PRATENSE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFLAMMATION; RHINITIS; SMOKING; ANIMAL; EXHALATION; EXPOSURE; HEALTH SURVEY; IMMUNIZATION; IMMUNOLOGY; INFLAMMATION; INHALATION TEST; METABOLISM; MIDDLE AGED; SWEDEN;

ADULT; ALLERGENS; ANIMALS; ASTHMA; BIOMARKERS; BRONCHIAL PROVOCATION TESTS; CATS; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; INFLAMMATION; INHALATION EXPOSURE; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; NITRIC OXIDE; RESPIRATORY TRACT DISEASES; RHINITIS; SWEDEN;

EID: 84964407309     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12607     Document Type: Article

References (45)

1. Nicolaou N, Siddique N, Custovic A. Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization. Allergy 2005; 60:1357-60.
2. Cox L, Williams B, Sicherer S et al. Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force. Annals Allergy Asthma Immunol 2008; 101:580-92.
3. Canonica GW, Ansotegui IJ, Pawankar R et al. A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 2013; 6:17.
4. Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29:896-904.
5. Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 2002; 127:259-68.
6. Harwanegg C, Laffer S, Hiller R et al. Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy 2003; 33:7-13.
7. Sastre J. Molecular diagnosis in allergy. Clin Exp Allergy 2010; 40:1442-60.
8. Nicolaou N, Poorafshar M, Murray C et al. Allergy or tolerance in children sensitised to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 2010; 125:e1-13.
9. Codreanu F, Collignon O, Roitel O et al. A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis. Int Arch Allergy Immunol 2011; 154:216-26.
10. Dang TD, Tang M, Choo S et al. Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. J Allergy Clin Immunol 2012; 129:1056-63.
11. Gadisseur R, Chapelle JP, Cavalier E. A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP(c) 250 with the ImmunoCAP(c) ISAC. Clin Chem Lab Med 2011; 49:277-80.
12. Bonini M, Marcomini L, Gramiccioni C et al. Microarray evaluation of specific IgE to allergen components in elite athletes. Allergy 2012; 67:1557-64.
13. Melioli G, Bonifazi F, Bonini S et al. The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitised Italian patients with respiratory symptoms. Clin Biochem 2011; 44:1005-11.
14. Prosperi MC, Belgrave D, Buchan I, Simpson A, Custovic A. Challenges in interpreting allergen microarrays in relation to clinical symptoms: a machine learning approach. Pediatric Allergy Immunol 2014; 25:71-9.
15. Moverare R, Elfman L, Vesterinen E, Metso T, Haahtela T. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002; 57:423-30.
16. Scaparrotta A, Verini M, Consilvio NP et al. Sensitisation to timothy grass pollen allergenic molecules in children. Multidis Res Med 2013; 8:17.
17. Rossi RE, Monasterolo G, Monasterolo S. Measurement of IgE antibodies against purified grass-pollen allergens (Phl p 1, 2, 3, 4, 5, 6, 7, 11, and 12) in sera of patients allergic to grass pollen. Allergy 2001; 56:1180-5.
18. Borres MP, Ebisawa M, Eigenmann PA. Use of allergen components begins a new era in pediatric allergology. Pediat Allergy Immunol 2011; 22:454-61.
19. Bronnert M, Mancini J, Birnbaum J et al. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy. Clin Exp Allergy 2012; 42:1406-15.
20. Konradsen JR, Nordlund B, Onell A, Borres MP, Gronlund H, Hedlin G. Severe childhood asthma and allergy to furry animals: refined assessment using molecular-based allergy diagnostics. Pediat Allergy Immunol 2014; 25:187-92.
21. Chinn S, Burney P, Sunyer J, Jarvis D, Luczynska C. Sensitisation to individual allergens and bronchial responsiveness in the ECRHS. European Community Respiratory Health Survey. The Euro Res J 1999; 14:876-84.
22. Patelis A, Janson C, Borres MP, Nordvall L, Alving K, Malinovschi A. Aeroallergen and food IgE sensitisation and local and systemic inflammation in asthma. Allergy 2014; 69:380-7.
23. Patelis A, Gunnbjornsdottir M, Malinovschi A et al. Population-based study of multiplexed IgE sensitisation in relation to asthma, exhaled nitric oxide, and bronchial responsiveness. J Allergy Clin Immunol 2012; 130:e2.
24. Jaakkola MS, Ieromnimon A, Jaakkola JJ. Are atopy and specific IgE to mites and molds important for adult asthma? J Allergy Clin Immunol 2006; 117:642-8.
25. Hatzler L, Panetta V, Lau S et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012; 130:e5.
26. Burney PG, Luczynska C, Chinn S, Jarvis D. The European Community Respiratory Health Survey. Euro Res J 1994; 7:954-60.
27. European Community Respiratory Health Survey II Steering Committee. The European Community Respiratory Health Survey II. Euro Res J 2002; 20:1071-9.
28. Bjerg A, Ekerljung L, Middelveld R et al. Increased prevalence of symptoms of rhinitis but not of asthma between 1990 and 2008 in Swedish adults: comparisons of the ECRHS and GA(2)LEN surveys. PLoS ONE 2011; 6:e16082.
29. Olafsdottir IS, Gislason T, Thjodleifsson B et al. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005; 60:451-4.
30. Malinovschi A, Janson C, Holmkvist T, Norback D, Merilainen P, Hogman M. IgE sensitisation in relation to flow-independent nitric oxide exchange parameters. Respir Res 2006; 7:92.
31. Hiller R, Laffer S, Harwanegg C et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002; 16:414-6.
32. Bousquet J, Chanez P, Chanal I, Michel FB. Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. J Allergy Clin Immunol 1990; 85:1039-43.
33. ATS/ERS. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-30.
34. Chinn S, Heinrich J, Anto JM et al. Bronchial responsiveness in atopic adults increases with exposure to cat allergen. Am J Respir Crit Care Med 2007; 176:20-6.
35. Smith W, O'Neil SE, Hales BJ et al. Two newly identified cat allergens: the von Ebner gland protein Fel d 7 and the latherin-like protein Fel d 8. Int Arch Allergy Immunol 2011; 156:159-70.
36. Kochuyt AM, Van Hoeyveld EM, Stevens EA. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms. Clin Exp Allergy 2005; 35:441-7.
37. Vieths S, Scheurer S, Ballmer-Weber B. Current understanding of cross-reactivity of food allergens and pollen. Ann N Y Acad Sci 2002; 964:47-68.
38. van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol 2002; 129:189-97.
39. Ichikawa K, Vailes LD, Pomes A, Chapman MD. Identification of a novel cat allergen-cystatin. Int Arch Allergy Immunol 2001; 124:55-6.
40. Adedoyin J, Gronlund H, Oman H, Johansson SG, van Hage M. Cat IgA, representative of new carbohydrate cross-reactive allergens. J Allergy Clin Immunol 2007; 119:640-5.
41. International Union of Immunological Societies Allergen Nomenclature: IUIS official list. http://www.allergenorg/2011.
42. Konradsen JR, Fujisawa T, van Hage M et al. Allergy to furry animals: new insights, diagnostic approaches, and challenges. J Allergy Clin Immunol 2015; 135:616-25.
43. Schafer T, Hoelscher B, Adam H, Ring J, Wichmann HE, Heinrich J. Hay fever and predictive value of prick test and specific IgE antibodies: a prospective study in children. Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology 2003; 14:120-9.
44. Bodtger U, Assing K, Poulsen LK. A prospective, clinical study on asymptomatic sensitisation and development of allergic rhinitis: high negative predictive value of allergological testing. Int Arch Allergy Immunol 2011; 155:289-96.
45. Anto JM, Sunyer J, Basagana X et al. Risk factors of new-onset asthma in adults: a population-based international cohort study. Allergy 2010; 65:1021-30.